Ophthalmic complications following treatment of paranasal sinus rhabdomyosarcoma in comparison to orbital disease.

Published

Journal Article

To identify the type and frequency of ocular and orbital complications observed following treatment for primary rhabdomyosarcoma of the paranasal sinuses or the orbit.An institutional review board-approved, Health Insurance Portability and Accountability Act-compliant retrospective chart review was conducted to identify all patients treated at one institution from 1966 to 2005 with biopsy-proven primary paranasal sinus or orbital rhabdomyosarcoma. Pretreatment, treatment, and follow-up data were collected.Forty-four patients (25 male) of a median age of 7.8 years (range 1.0-18.0 years) with primary paranasal sinus (17) or orbital (27) rhabdomyosarcoma were treated and followed for a median period of 5.3 years (range 0.6-32.0 years). The three most frequently observed ophthalmic complications were persistent eyelid erythema or cellulitis (12), epithelial keratitis (7), and conjunctival injection (6) in the paranasal sinus and epithelial keratitis (18), conjunctival injection (11), and cataract (10) in the orbit. Overall survival after treatment trended higher for the orbital rhabdomyosarcoma group (23 of 27) than the paranasal sinus group (9 of 17).The most frequently observed treatment-induced ophthalmic complications in the paranasal sinus group were manageable with minimal patient morbidity, as in the patients with orbital disease. Vision-threatening complications were infrequently encountered. Despite maximal therapy, the mortality rate was higher in the paranasal sinus rhabdomyosarcoma group than in the orbital rhabdomyosarcoma group.

Full Text

Cited Authors

  • Gandhi, PD; Fleming, JC; Haik, BG; Wilson, MW

Published Date

  • July 2011

Published In

Volume / Issue

  • 27 / 4

Start / End Page

  • 241 - 246

PubMed ID

  • 21242849

Pubmed Central ID

  • 21242849

Electronic International Standard Serial Number (EISSN)

  • 1537-2677

International Standard Serial Number (ISSN)

  • 0740-9303

Digital Object Identifier (DOI)

  • 10.1097/iop.0b013e318203d5e8

Language

  • eng